Literature DB >> 15224208

Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.

A E Pontiroli1, P Pizzocri, A Caumo, G Perseghin, L Luzi.   

Abstract

We evaluated both insulin release (IR) and insulin sensitivity (IS) through a single oral glucose tolerance test (OGTT) (blood samples at 0, 60, 120 min, as routinely performed in Europe) in subjects with normal and abnormal glucose tolerance. The value 1/HOMA was used as an index of IS and deltaI/deltaG at 60 min was used as an index of IR. In preliminary experiments, 1/HOMA correlated with glucose infusion rate (GIR) at euglycaemic insulin clamp (r=0.495) and with insulin sensitivity index (ISI) at LDIGIT (r=0.714). At OGTT with blood samples at 0, 30, 60 and 120 min, insulin levels at 30 min correlated with insulin levels at 60 min (I30 vs. I60, r=0.584) and deltaI/deltaG at 30 and at 60 min correlated (r=0.365). Values of 1/HOMA from 345 subjects with normal glucose tolerance (NGT), 32 with impaired fasting glucose (IFG), 186 with impaired glucose tolerance (IGT) and 72 with type 2 diabetic mellitus were divided into quartiles. For each quartile, mean (+/- SE) and 95% confidence intervals (CI) of deltaI/deltaG at 60 min were calculated, and subjects were represented by plotting IS vs. IR. Plots of NGT, IGT, and type-2 diabetes mellitus described different curves. Values of subjects with IFG, IGT and type 2 diabetes mellitus fell outside the 95% CI of NGT subjects in all quartiles of IS. To validate this finding, 113 morbidly obese subjects (basal OGTT: 55 NGT, 40 IGT, 18 T2DM) who underwent a major reduction of body weight through bariatric surgery received a second OGTT one year after surgery. Glucose tolerance improved in 40 patients, deteriorated in 8, did not change in 65; the new plots were concordant with the new class of glucose tolerance. OGTT can be used to evaluate both IR and IS in subjects with NGT, IFG, IGT, and type 2 diabetes mellitus in population studies and in follow-up studies. IFG, IGT and type 2 diabetes mellitus are characterized by reduced IR compared to IS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15224208     DOI: 10.1007/s00592-004-0147-x

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  6 in total

1.  Glucose metabolism disorder in obese children assessed by continuous glucose monitoring system.

Authors:  Chao-Chun Zou; Li Liang; Fang Hong; Zheng-Yan Zhao
Journal:  World J Pediatr       Date:  2008-02       Impact factor: 2.764

2.  Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study.

Authors:  Fida Bacha; Laura Pyle; Kristen Nadeau; Leona Cuttler; Robin Goland; Morey Haymond; Lynne Levitsky; Jane Lynch; Ruth S Weinstock; Neil H White; Sonia Caprio; Silva Arslanian
Journal:  Pediatr Diabetes       Date:  2012-02-15       Impact factor: 4.866

3.  Novel biomarkers for pre-diabetes identified by metabolomics.

Authors:  Rui Wang-Sattler; Zhonghao Yu; Christian Herder; Ana C Messias; Anna Floegel; Ying He; Katharina Heim; Monica Campillos; Christina Holzapfel; Barbara Thorand; Harald Grallert; Tao Xu; Erik Bader; Cornelia Huth; Kirstin Mittelstrass; Angela Döring; Christa Meisinger; Christian Gieger; Cornelia Prehn; Werner Roemisch-Margl; Maren Carstensen; Lu Xie; Hisami Yamanaka-Okumura; Guihong Xing; Uta Ceglarek; Joachim Thiery; Guido Giani; Heiko Lickert; Xu Lin; Yixue Li; Heiner Boeing; Hans-Georg Joost; Martin Hrabé de Angelis; Wolfgang Rathmann; Karsten Suhre; Holger Prokisch; Annette Peters; Thomas Meitinger; Michael Roden; H-Erich Wichmann; Tobias Pischon; Jerzy Adamski; Thomas Illig
Journal:  Mol Syst Biol       Date:  2012       Impact factor: 11.429

4.  Response to comment on Dutia et al. Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission. Diabetes 2014;63:1214-1223.

Authors:  Roxanne Dutia; Katrina Brakoniecki; Phoebe Bunker; Furcy Paultre; Peter Homel; André C Carpentier; James McGinty; Blandine Laferrère
Journal:  Diabetes       Date:  2014-04       Impact factor: 9.461

Review 5.  MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related Complications.

Authors:  Suniti Vaishya; Rucha D Sarwade; Vasudevan Seshadri
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-23       Impact factor: 5.555

6.  Pregnancy Serum DLK1 Concentrations Are Associated With Indices of Insulin Resistance and Secretion.

Authors:  Clive J Petry; Keith A Burling; Peter Barker; Ieuan A Hughes; Ken K Ong; David B Dunger
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.